Exhibit 99.1
DATE: February 16, 2010
FOR IMMEDIATE RELEASE
AMERICAN MEDICAL SYSTEMS CONFIRMS FOURTH QUARTER REVENUE AND FINISHES 2009 WITH STRONG FINANCIAL PERFORMANCE
    Fourth quarter non-GAAP adjusted EPS of $0.35 grows 17% over prior year; GAAP EPS of $0.30 exceeds prior year by $0.17
 
    Continued solid cash management results in 2009 debt reduction of $131 million
MINNEAPOLIS, February 16, 2010 — American Medical Systems Holdings, Inc. (NASDAQ: AMMD) confirmed previously reported revenue of $146.0 million for the fourth quarter of 2009, a 9.0 percent increase from revenue of $134.0 million in the comparable quarter of 2008. Adjusting for the positive impact of the weaker U.S. dollar in the fourth quarter of 2009 versus the same quarter last year results in constant currency growth of 6.1 percent. Full year 2009 revenue of $519.3 million grew 3.5 percent over 2008 revenue of $501.6 million. Adjusting for the negative impact of foreign currency fluctuations in 2009 compared to 2008 results in constant currency growth of 5.2 percent.
Men’s Health sales of $63.5 million in the fourth quarter represented an increase of 8.2 percent on a reported basis compared to the same quarter last year and grew 5.2 percent on a constant currency basis. Growth in this business was led by the Erectile Restoration product line which continued its strong performance in the fourth quarter, but was partially offset by muted growth in Male Continence. The BPH therapy business increased 10.3 percent on a reported basis and grew 6.5 percent on a constant currency basis to $33.3 million during the quarter, driven by continued strength in the U.S. combined with notable improvement in international markets, particularly in Asia Pacific and Latin America. The Women’s Health business increased 8.9 percent on a reported basis and 6.9 percent on a constant currency basis to $49.2 million in the fourth quarter. Pelvic Floor Repair continued twenty percent plus growth in the fourth quarter, driven by the launch of Elevate® anterior in mid-2009. This strong growth was partially reduced by soft Female Continence product sales in the quarter and, as anticipated, sales from uterine health declined in the quarter, although at a lesser pace than previous quarters.
On a GAAP basis, the Company reported net income for the fourth quarter of 2009 of $22.3 million, or $0.30 per share, compared to net income in the same period last year of $9.4 million, or $0.13 per share. Included in the fourth quarter 2008 net income was a $17.1 million charge for accelerated amortization of certain intangible assets related to our TherMatrx® and GreenLight PV ® product lines and a $5.6 million gain related to early extinguishment of debt purchased at a discount to face value.
The Company also reported very strong non-GAAP adjusted EPS performance in the fourth quarter of 2009 of $0.35 per share compared to $0.30 per share in the comparable period last year. Non-GAAP adjusted EPS excludes the impact of the amortization of intangible assets and amortization of financing costs, both significant non-cash items affecting comparability to other

 


The following information was filed by American Medical Systems Holdings Inc on Tuesday, February 16, 2010 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate American Medical Systems Holdings Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Medical Systems Holdings Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account